NeoImmuneTech, Inc. (KOSDAQ:950220)
468.00
-4.00 (-0.85%)
Apr 30, 2026, 3:30 PM KST
NeoImmuneTech Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 38,836 | 34,172 | 68,739 | 115,630 | 154,250 |
Short-Term Investments | 11,500 | - | 333.38 | 1,445 | 220.29 |
Trading Asset Securities | 10,487 | 447.36 | - | - | - |
Cash & Short-Term Investments | 60,822 | 34,619 | 69,072 | 117,075 | 154,471 |
Cash Growth | 75.69% | -49.88% | -41.00% | -24.21% | 116.90% |
Accounts Receivable | 32.37 | 20.37 | - | - | - |
Receivables | 32.37 | 20.37 | - | - | - |
Prepaid Expenses | 2,291 | 4,446 | - | 895.8 | - |
Other Current Assets | 658.24 | 249.76 | 3,185 | -0 | 12,252 |
Total Current Assets | 63,804 | 39,335 | 72,257 | 117,971 | 166,722 |
Property, Plant & Equipment | 4,631 | 6,771 | 7,749 | 9,397 | 9,056 |
Other Intangible Assets | 12,820 | 6,461 | 6,168 | 6,554 | 6,591 |
Other Long-Term Assets | 793.75 | 12,858 | 4,338 | 5,944 | 4,659 |
Total Assets | 82,048 | 65,426 | 90,511 | 139,865 | 187,027 |
Accrued Expenses | 3,960 | 6,316 | 7,717 | 12,945 | 17,426 |
Short-Term Debt | 7,630 | 6,935 | - | - | - |
Current Portion of Leases | 927.41 | 1,150 | 1,353 | 1,279 | 1,284 |
Current Income Taxes Payable | - | - | - | 92.49 | 59.33 |
Other Current Liabilities | 8,169 | 6,385 | 3,816 | 2,080 | 1,642 |
Total Current Liabilities | 20,686 | 20,785 | 12,886 | 16,397 | 20,411 |
Long-Term Leases | 1,934 | 2,686 | 2,555 | 3,572 | 4,511 |
Pension & Post-Retirement Benefits | 169.14 | 257.11 | 151.69 | 142.43 | - |
Other Long-Term Liabilities | 46.25 | 36.29 | 62.24 | 64.34 | 63.09 |
Total Liabilities | 22,836 | 23,764 | 15,655 | 20,176 | 24,985 |
Common Stock | 4.81 | 2.91 | 2.55 | 2.51 | 2.34 |
Additional Paid-In Capital | 380,009 | 337,199 | 295,772 | 290,644 | 271,282 |
Retained Earnings | -349,508 | -325,185 | -246,517 | -190,424 | -122,781 |
Comprehensive Income & Other | 28,706 | 29,645 | 25,599 | 19,466 | 13,539 |
Shareholders' Equity | 59,212 | 41,662 | 74,856 | 119,689 | 162,042 |
Total Liabilities & Equity | 82,048 | 65,426 | 90,511 | 139,865 | 187,027 |
Total Debt | 10,492 | 10,771 | 3,908 | 4,851 | 5,795 |
Net Cash (Debt) | 50,330 | 23,849 | 65,164 | 112,224 | 148,676 |
Net Cash Growth | 111.04% | -63.40% | -41.93% | -24.52% | 117.64% |
Net Cash Per Share | 427.71 | 241.85 | 659.23 | 1136.26 | 1560.75 |
Filing Date Shares Outstanding | 143.19 | 494.34 | 494.34 | 494.14 | 492.91 |
Total Common Shares Outstanding | 143.19 | 494.34 | 494.34 | 494.14 | 492.91 |
Working Capital | 43,117 | 18,550 | 59,371 | 101,574 | 146,311 |
Book Value Per Share | 413.52 | 84.28 | 151.43 | 242.22 | 328.75 |
Tangible Book Value | 46,392 | 35,200 | 68,689 | 113,136 | 155,452 |
Tangible Book Value Per Share | 323.99 | 71.21 | 138.95 | 228.96 | 315.38 |
Machinery | 4,337 | 6,530 | 5,727 | 4,864 | 3,027 |
Construction In Progress | - | - | - | - | 764.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.